Addex Therapeutics Ltd banner

Addex Therapeutics Ltd
SIX:ADXN

Watchlist Manager
Addex Therapeutics Ltd Logo
Addex Therapeutics Ltd
SIX:ADXN
Watchlist
Price: 0.045 CHF Market Closed
Market Cap: CHf8.3m

Cash Flow Statement

Cash Flow Statement
Addex Therapeutics Ltd

Rotate your device to view
Cash Flow Statement
Currency: CHF
Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
6
(3)
1
(2)
(12)
(15)
(19)
(15)
(18)
(13)
(11)
(13)
(13)
(15)
(19)
(21)
(22)
(21)
(17)
(13)
(11)
(11)
(11)
4
5
7
9
(6)
(6)
Depreciation & Amortization
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
0
1
0
2
0
2
0
0
0
1
0
0
1
1
2
0
3
4
2
2
0
2
2
2
2
2
2
2
2
Other Non-Cash Items
1
1
1
3
3
2
3
2
3
2
1
1
1
1
3
3
3
4
3
3
2
2
2
(12)
(12)
(11)
(11)
4
4
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
(0)
0
0
1
2
3
2
(3)
(3)
(2)
(1)
(0)
0
(1)
(2)
1
1
0
0
(1)
(2)
0
1
(0)
(0)
(1)
(2)
1
1
Cash from Operating Activities
6
N/A
(2)
N/A
2
N/A
2
-30%
(6)
N/A
(9)
-47%
(14)
-44%
(15)
-11%
(18)
-17%
(12)
+31%
(11)
+11%
(11)
-3%
(11)
+0%
(15)
-33%
(17)
-14%
(16)
+4%
(16)
-1%
(16)
-1%
(14)
+15%
(11)
+22%
(10)
+4%
(8)
+23%
(8)
-2%
(8)
+4%
(6)
+24%
(5)
+10%
(3)
+35%
(1)
+59%
(2)
-9%
Investing Cash Flow
Capital Expenditures
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
Other Items
(0)
0
0
(0)
0
(0)
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
0
(1)
(1)
Cash from Investing Activities
(0)
N/A
(0)
+100%
(0)
-300%
(0)
-1 914%
(0)
-36%
(0)
+44%
(0)
-20%
(0)
+39%
(0)
-2%
(0)
-85%
(0)
+9%
(0)
0%
(0)
+0%
(0)
+44%
(0)
+11%
(0)
+8%
(0)
+14%
0
N/A
0
-83%
(0)
N/A
(0)
-185%
(0)
-19%
(0)
+35%
5
N/A
5
0%
5
0%
0
N/A
(1)
N/A
(1)
+9%
Financing Cash Flow
Net Issuance of Common Stock
0
3
40
40
0
0
0
(0)
(0)
1
11
11
11
19
8
8
10
4
6
9
7
4
4
(0)
(0)
(0)
(0)
0
0
Net Issuance of Debt
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other
4
(0)
(3)
(3)
(0)
(0)
(0)
(0)
(0)
(0)
(2)
(2)
(2)
(2)
(1)
(1)
2
(1)
(0)
1
(2)
1
1
0
0
0
0
1
1
Cash from Financing Activities
4
N/A
3
-4%
38
+1 020%
37
-1%
(0)
N/A
(0)
-30%
(1)
-45%
(1)
+22%
(1)
-18%
0
N/A
9
+19 401%
9
-4%
9
+0%
16
+88%
7
-58%
7
+4%
11
+60%
3
-73%
5
+57%
10
+95%
5
-46%
5
+2%
4
-16%
(0)
N/A
0
N/A
0
+117%
0
-63%
1
+1 840%
1
+49%
Change in Cash
Effect of Foreign Exchange Rates
(0)
(0)
(0)
0
0
(0)
(0)
(0)
(1)
(1)
(0)
(0)
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
Net Change in Cash
9
N/A
1
-87%
40
+3 306%
39
-2%
(7)
N/A
(10)
-49%
(15)
-44%
(16)
-11%
(19)
-18%
(13)
+32%
(2)
+85%
(3)
-34%
(2)
+9%
2
N/A
(10)
N/A
(9)
+10%
(5)
+46%
(14)
-167%
(9)
+31%
(2)
+82%
(6)
-245%
(3)
+45%
(4)
-28%
(3)
+15%
(1)
+58%
(1)
+63%
1
N/A
(1)
N/A
(1)
+22%
Free Cash Flow
Free Cash Flow
6
N/A
(2)
N/A
2
N/A
2
-30%
(6)
N/A
(10)
-47%
(14)
-44%
(15)
-11%
(18)
-17%
(12)
+31%
(11)
+11%
(11)
-3%
(11)
+0%
(15)
-33%
(17)
-14%
(16)
+4%
(16)
-1%
(16)
-1%
(14)
+15%
(11)
+22%
(10)
+4%
(8)
+23%
(8)
-2%
(8)
+4%
(6)
+24%
(5)
+10%
(3)
+35%
(1)
+59%
(2)
-9%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett